WeVote
Log In

Bill

Bill

S 717

Exempts Wantagh school district from regulations regarding the use of indigenous mascots

2025 Regular Session Introduced by Steve Rhoads

Expands HIV PrEP access across MA systems (GIC, MassHealth, correctional facilities) with no cost-sharing or prior authorizations, plus pre-release supplies and linkage to care.

REFERRED TO EDUCATION
0
WeVote Research Nonpartisan
Bill Summary · S 717

Bill Summary — S 717 (filed as “An Act to strengthen the control of contagious and infectious diseases in the Commonwealth”)

Important note on inconsistencies: the metadata you provided (title: “Exempts Wantagh school district from regulations regarding the use of indigenous mascots”; committee referrals including Education; listed sponsors) does not match the full bill text included below, which is a Massachusetts state bill focused on HIV prevention (pre‑exposure prophylaxis, PrEP) coverage and correctional‑system delivery. This summary is based on the bill text you provided (Senate Docket No. 1685 / S.717 — public‑health/PrEP provisions). Verify the correct bill number/title if you need the mascot exemption matter summarized.

Purpose

To expand and strengthen access to HIV pre‑exposure prophylaxis (PrEP) and associated services across several state systems in Massachusetts — specifically: (1) group health insurance for commonwealth employees, (2) state Medicaid/Chapter 118E coverage, and (3) pre‑release services in state and county correctional facilities — in order to reduce HIV transmission.

Key provisions

  • Definitions: Establishes definitions for “HIV” and “HIV prevention drug” (FDA‑approved PrEP drugs and associated ancillary/support services required for safe, effective use).
  • State employee coverage (Chapter 32A, new §17T):
    • The Group Insurance Commission (GIC) must cover HIV prevention drugs for active and retired commonwealth employees.
    • Coverage must be provided without any cost‑sharing (no copays, coinsurance, or deductibles).
    • Plans may not impose prior authorization, step therapy, or other protocols that restrict or delay access.
    • Prescriptions cannot be denied based on the prescriber’s licensure category or practice setting (so long as prescriber is licensed to prescribe).
  • Medicaid/Division coverage (Chapter 118E, new §10R):
    • The Division (MassHealth) must provide PrEP coverage under the same rules: no cost‑sharing, no prior authorization/step therapy, and cannot deny based on prescriber type or setting.
  • Correctional facilities (Chapter 127, new §17E):
    • Superintendents/administrators must ensure that, prior to release, eligible inmates who are HIV‑negative receive counseling and information about PrEP, be evaluated for PrEP eligibility, and — with consent — receive a pre‑release supply.
    • The pre‑release supply options include administration of the longest‑duration injectable PrEP immediately prior to release, a 90‑day oral supply, other clinically appropriate PrEP, or a prescription to be filled post‑release.
    • Facilities must develop plans to connect inmates who receive PrEP to post‑release medical and supportive services to maintain ongoing therapy.
    • Pre‑release PrEP supplies are provided at no cost to the inmate.
    • Evaluations for PrEP must be kept confidential between inmate and medical provider (not shared with security/staff) — provision text is truncated but confidentiality is specified.

Who is affected

  • Active and retired commonwealth employees and their dependents covered under the GIC.
  • MassHealth/Medicaid enrollees.
  • Inmates in state correctional facilities and county inmates committed to 30 days or more.
  • Health care providers (prescribers, correctional health staff) and payers (GIC, MassHealth, state/local correctional health budgets).
  • Pharmacies and community providers responsible for post‑release follow‑up.

Procedural/status notes

  • Introduced in the Senate (filed 1/16/2025 per docket); bill text shows presented by Julian Cyr.
  • Legislative actions in your data show read/fiscal referrals and hearing scheduling:
    • Read twice and referred to Committee on Finance (2/25/2025).
    • Hearing scheduled for 09/17/2025 (12:30–4:30 PM) in Gardner Auditorium.
  • Some of the status lines you provided conflict (mentions of Education committee, differing referral entries). Confirm committee and current location in the legislative process with the official legislative website.

Potential impacts

  • Access: Likely to substantially increase timely access to PrEP across target populations by removing cost and administrative barriers.
  • Public health: Could reduce new HIV infections and downstream treatment costs if uptake and retention in care are achieved.
  • Fiscal: Short‑term increases in drug and service expenditures for state employee plans, MassHealth, and correctional health programs; potential long‑term savings from prevented HIV infections.
  • Implementation: Requires operational work — GIC and MassHealth policy changes, correctional facility protocols for evaluation, supply logistics, and post‑release care coordination.

Caveat

Portions of the bill text were truncated in the provided document (especially later correctional confidentiality/administration details). For final legislative language, fiscal analyses, and committee actions, consult the official bill file and fiscal notes on the Massachusetts Legislature website.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.